Literature DB >> 18305403

Alterations of proliferative and differentiation potentials of human embryonic stem cells during long-term culture.

Yong Bin Park1, Yoon Young Kim, Sun Kyung Oh, Sun Gan Chung, Seung Yup Ku, Seok Hyun Kim, Young Min Choi, Shin Yong Moon.   

Abstract

Human embryonic stem cells (hESCs) are considered to be able to stably maintain their characteristics in vitro for prolonged periods, but we had previously encountered changes in proliferative ability and differentiation potential during extended culture of hESCs. Therefore, we investigated the proliferative ability and differentiation potential of hESCs during long-term culture. The hESCs, SNUhES3, were used to analyze population-doubling time, proliferation rate and differentiation potential. We classified hESCs into three groups according to culture period. Ten colonies of hESCs for each group were daily measured colony area and population-doubling time was assessed by the changes of colony area. Proliferation rate of hESCs was measured by 5-bromo-2'-deoxyuridine (BrdU) assay and telomerase activity. To evaluate differentiation potentials for hESCs, expression levels of undifferentiated and/or differentiated hESCs markers were examined by FACS, RT-PCR and immunostaining. Population-doubling time of early passage hESCs was longer than those of middle or late passage. Proliferative ability of hESCs was accelerated depending on culture periods. Cellular morphologies and the expression level of each three germ layer markers were obviously different from each passage of reattached embryoid bodies (EBs) after spontaneous differentiation. Differentiated cells of late passage expressed higher levels of undifferentiated markers such as Oct4 and SSEA4 than those of early and middle passage. But differentiated cells of early and middle passage expressed higher level of differentiated state markers, Nestin (ectoderm), Brachyury (mesoderm), HNF3beta (endoderm). From these results, it can be inferred that hESCs show higher proliferative abilities and reduced differentiation potentials as the passage number increased. Therefore, we conclude that early passage hESCs could be more suitable than middle and late passage hESCs in differentiation studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18305403      PMCID: PMC2679310          DOI: 10.3858/emm.2008.40.1.98

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  34 in total

1.  Pluripotent cell division cycles are driven by ectopic Cdk2, cyclin A/E and E2F activities.

Authors:  Elaine Stead; Josephine White; Renate Faast; Simon Conn; Sherilyn Goldstone; Joy Rathjen; Urvashi Dhingra; Peter Rathjen; Duncan Walker; Stephen Dalton
Journal:  Oncogene       Date:  2002-11-28       Impact factor: 9.867

2.  Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytes.

Authors:  Mirit Snir; Izhak Kehat; Amira Gepstein; Raymond Coleman; Joseph Itskovitz-Eldor; Erella Livne; Lior Gepstein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-12       Impact factor: 4.733

3.  Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro.

Authors:  B E Reubinoff; M F Pera; C Y Fong; A Trounson; A Bongso
Journal:  Nat Biotechnol       Date:  2000-04       Impact factor: 54.908

Review 4.  Embryo-derived stem cells: of mice and men.

Authors:  A G Smith
Journal:  Annu Rev Cell Dev Biol       Date:  2001       Impact factor: 13.827

Review 5.  Survivin - an anti-apoptosis protein: its biological roles and implications for cancer and beyond.

Authors:  Shiun-Kwei Chiou; Michael K Jones; Andrzej S Tarnawski
Journal:  Med Sci Monit       Date:  2003-04

6.  Stable genetic modification of human embryonic stem cells by lentiviral vectors.

Authors:  Michal Gropp; Pavel Itsykson; Orna Singer; Tamir Ben-Hur; Etti Reinhartz; Eithan Galun; Benjamin E Reubinoff
Journal:  Mol Ther       Date:  2003-02       Impact factor: 11.454

Review 7.  Signalling, cell cycle and pluripotency in embryonic stem cells.

Authors:  Tom Burdon; Austin Smith; Pierre Savatier
Journal:  Trends Cell Biol       Date:  2002-09       Impact factor: 20.808

8.  Human embryonic stem cell-derived neural precursors as a continuous, stable, and on-demand source for human dopamine neurons.

Authors:  Ji-Yun Ko; Chang-Hwan Park; Hyun-Chul Koh; Youl-Hee Cho; Jee-Hong Kyhm; Young-Soo Kim; Inchul Lee; Yong-Sung Lee; Sang-Hun Lee
Journal:  J Neurochem       Date:  2007-09-13       Impact factor: 5.372

9.  Generation of hepatocyte-like cells from human embryonic stem cells.

Authors:  Lakshmi Rambhatla; Choy-Pik Chiu; Pratima Kundu; Yun Peng; Melissa K Carpenter
Journal:  Cell Transplant       Date:  2003       Impact factor: 4.064

10.  High-level sustained transgene expression in human embryonic stem cells using lentiviral vectors.

Authors:  Yue Ma; Ali Ramezani; Rachel Lewis; Robert G Hawley; James A Thomson
Journal:  Stem Cells       Date:  2003       Impact factor: 6.277

View more
  19 in total

Review 1.  Induced pluripotent stem cells: emerging techniques for nuclear reprogramming.

Authors:  Ji Woong Han; Young-Sup Yoon
Journal:  Antioxid Redox Signal       Date:  2011-05-05       Impact factor: 8.401

2.  Transcriptional expression profile of cultured human embryonic stem cells in vitro and in vivo.

Authors:  Marlen Keil; Antje Siegert; Klaus Eckert; Jörg Gerlach; Wolfram Haider; Iduna Fichtner
Journal:  In Vitro Cell Dev Biol Anim       Date:  2012-02-04       Impact factor: 2.416

3.  Teratoma formation: a tool for monitoring pluripotency in stem cell research.

Authors:  Raman V Nelakanti; Nigel G Kooreman; Joseph C Wu
Journal:  Curr Protoc Stem Cell Biol       Date:  2015-02-02

Review 4.  Stem cell-based therapies for spinal cord injury.

Authors:  Rishi S Nandoe Tewarie; Andres Hurtado; Ronald H Bartels; Andre Grotenhuis; Martin Oudega
Journal:  J Spinal Cord Med       Date:  2009       Impact factor: 1.985

5.  Effects of long-term culture on human embryonic stem cell aging.

Authors:  Xiaoyan Xie; Asimina Hiona; Andrew Stephen Lee; Feng Cao; Mei Huang; Zongjin Li; Athena Cherry; Xuetao Pei; Joseph C Wu
Journal:  Stem Cells Dev       Date:  2010-09-09       Impact factor: 3.272

6.  Evaluating differentiation propensity of in-house derived human embryonic stem cell lines KIND-1 and KIND-2.

Authors:  Punam Nagvenkar; Prasad Pethe; Harsha Pawani; Jyoti Telang; Neeraj Kumar; Indira Hinduja; Kusum Zaveri; Deepa Bhartiya
Journal:  In Vitro Cell Dev Biol Anim       Date:  2011-05-26       Impact factor: 2.416

Review 7.  A review of the emerging potential therapy for neurological disorders: human embryonic stem cell therapy.

Authors:  Geeta Shroff; Jyoti Dhanda Titus; Rhea Shroff
Journal:  Am J Stem Cells       Date:  2017-04-15

8.  Reactive oxygen species enhance differentiation of human embryonic stem cells into mesendodermal lineage.

Authors:  Ae-Ri Ji; Seung-Yup Ku; Myung Soo Cho; Yoon Young Kim; Yong Jin Kim; Sun Kyung Oh; Seok Hyun Kim; Shin Yong Moon; Young Min Choi
Journal:  Exp Mol Med       Date:  2010-03-31       Impact factor: 8.718

9.  Noninvasive de novo imaging of human embryonic stem cell-derived teratoma formation.

Authors:  Feng Cao; Zibo Li; Andrew Lee; Zhaofei Liu; Kai Chen; Hui Wang; Weibo Cai; Xiaoyuan Chen; Joseph C Wu
Journal:  Cancer Res       Date:  2009-03-24       Impact factor: 12.701

Review 10.  Concise Review: Control of Cell Fate Through Cell Cycle and Pluripotency Networks.

Authors:  Ben Boward; Tianming Wu; Stephen Dalton
Journal:  Stem Cells       Date:  2016-03-16       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.